Oral anti-diabetic drugs for the prevention of Type 2 diabetes
Posted on Mon, Jul 18, 2011
Oral anti-diabetic drugs for the prevention of Type 2 diabetes
Diabetic Medicine, 07/18/2011 Clinical Article
Phung OJ et al. – Of the oral anti–diabetic drugs evaluated to prevent Type 2 diabetes, thiazolidinediones were associated with the greatest risk reduction compared with control and associated with greater risk reduction than biguanides. Alpha–glucosidase inhibitors and biguanides performed similarly, and better than control, while sulphonylureas and glinides provided no significant benefit.
Methods
- A systematic literature search of MEDLINE, EMBASE and Cochrane CENTRAL was conducted for randomized controlled trials evaluating oral anti–diabetic drugs in patients at high risk for developing Type 2 diabetes.
- Mixed–treatment comparison meta–analysis methods were used to evaluate the relative risks and risk differences of developing Type 2 diabetes, along with associated 95% credible intervals.
Results
- 20 trials (n=23230 participants) were included.
- Upon mixed–treatment comparison meta–analysis, thiazolidinediones, alpha–glucosidase inhibitors and biguanides significantly reduced the relative risk of developing diabetes by 64, 40 and 27%, respectively, compared with control.
- Sulphonylureas and glinides showed no significant effect.
- thiazolidinediones significantly reduced the relative risk of ...read more
Read all
Family Medicine articles at
MDLinx.com